DOI: 10.1055/s-00000071

Seminars in Neurology

References

Khan O, Rieckmann P, Boyko A. , et al.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.

Mult Scler 2017;
23 (06) 818-829

Download Bibliographical Data

Access:
Access: